Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · see citing works

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,784 · see citing works

DNA methylation landscapes: Provocative insights from epigenomics

Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · see citing works

The ENCODE (ENCyclopedia Of DNA Elements) Project

(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390 · see citing works

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,545 · see citing works

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425 · see citing works

Nitric Oxide Synthases: Properties and Catalytic Mechanism

Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311 · see citing works

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881 · see citing works

The biosynthesis and functional role of cardiolipin

Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810 · see citing works

Epigenetics: Definition, Mechanisms and Clinical Perspective

Dupont, C., Armant, D. R., & Brenner, C. A. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1237423 · Cited by 805 · see citing works

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 770 · see citing works

Non-coding RNAs as regulators of gene expression and epigenetics

Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764 · see citing works

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Curigliano, G., Cardinale, D. M., Dent, S. F., Criscitiello, C., Aseyev, O., Lenihan, D. J., & Cipolla, C. M. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 728 · see citing works

Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy

Kalay, N., Başar, E., Özdoğru, İ., Er, O. S., Çetinkaya, Y., Doğan, A., Oğuzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 708 · see citing works

Molecular mechanism of doxorubicin-induced cardiomyopathy – An update

Renu, K., Gopalakrishnan, A. V., Pichiah, P. B. T., & Arunachalam, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 591 · see citing works

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

Frederick, C. A., Williams, L. D., Ughetto, G., MAREL, G. A. V. D., BOOM, J. H. V., Rich, A., & Wang, A. H. ‐. (1990) · Biochemistry · doi:10.1021/bi00462a016 · Cited by 578 · see citing works

The anthracyclines: will we ever find a better doxorubicin?

Weiss, R. B. (1992) · PubMed · Cited by 558 · see citing works

DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria

Shock, L. S., Thakkar, P. V., Peterson, E. J., Moran, R. G., & Taylor, S. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012311108 · Cited by 555 · see citing works

Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention

Henriksen, P. A. (2017) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 540 · see citing works

The apoptotic signaling pathway activated by Toll‐like receptor‐2

Aliprantis, A. O., Yang, R., Weiss, D. S., Godowski, P., & Zychlinsky, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3325 · Cited by 502 · see citing works

Energy metabolism in heart failure

Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 499 · see citing works

NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

Wojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A. G., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M. R., Suk, E.-K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.576850 · Cited by 490 · see citing works

Anthracycline Cardiotoxicity: From Bench to Bedside

Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N. A., & Sawyer, D. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9401 · Cited by 454 · see citing works

Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., & Gewirtz, D. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10149-1 · Cited by 436 · see citing works

Transcriptional and Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase Expression by Hydrogen Peroxide

Drummond, G. R., Cai, H., Davis, M. E., Ramasamy, S., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.86.3.347 · Cited by 430 · see citing works

Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.

Momparler, R. L., Karon, M. R., Siegel, S. E., & Avila, F. (1976) · PubMed · Cited by 423 · see citing works

Clinical Pharmacokinetics of Doxorubicin

Speth, P. A. J., van Hoesel, Q. G. C. M., & Haanen, C. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815010-00002 · Cited by 422 · see citing works

Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T. A., Kerkhoven, R. M., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 417 · see citing works

One-Carbon Metabolism: Linking Nutritional Biochemistry to Epigenetic Programming of Long-Term Development

Clare, C., Brassington, A. H., Kwong, W. Y., & Sinclair, K. D. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115206 · Cited by 399 · see citing works

Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma

Northfelt, D., Martin, F. J., Working, P. K., Volberding, P. A., Russell, J., Newman, M., Amantea, M., & Kaplan, L. D. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04152.x · Cited by 377 · see citing works

Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

Mukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 377 · see citing works

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes

Zhao, L., & Zhang, B. (2017) · Scientific Reports · doi:10.1038/srep44735 · Cited by 377 · see citing works

Adiponectin: Role in Physiology and Pathophysiology

Nguyen, T. M. D. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_193_20 · Cited by 374 · see citing works

Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin

Vasquez-Vivar, J. M., Pavel Martasek, E., Hogg, N., Masters, B. S. S., Pritchard, K. A., & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366 · see citing works

Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity

Fisher, P. W., Salloum, F. N., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 350 · see citing works

Curcumin

Lestari, M. L. A. D., & Indrayanto, G. (2014) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/b978-0-12-800173-8.00003-9 · Cited by 350 · see citing works

Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway

Ren, H., Shao, Y., Wu, C., Ma, X., Lv, C., & Wang, Q. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110628 · Cited by 313 · see citing works

Doxorubicin induced heart failure: Phenotype and molecular mechanisms

Mitry, M. A., & Edwards, J. G. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.11.004 · Cited by 312 · see citing works

Evidence of a specific complex between adriamycin and negatively-charged phospholipids

Goormaghtigh, E., Chatelain, P., Caspers, J., & Ruysschaert, J. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90145-5 · Cited by 310 · see citing works

Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.

Zhou, S., Starkov, A. A., Froberg, M. K., Leino, R. L., & Wallace, K. B. (2001) · PubMed · Cited by 310 · see citing works

Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes

Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 303 · see citing works

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity

Koleini, N., & Kardami, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16944 · Cited by 302 · see citing works

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity

Aries, A., Paradis, P., Lefèbvre, C., Schwartz, R. J., & Nemer, M. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 295 · see citing works

Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

Wang, S., Kotamraju, S., Konorev, E. A., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Biochemical Journal · doi:10.1042/bj20020752 · Cited by 286 · see citing works

Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death

Kobayashi, S., Volden, P. A., Timm, D. J., Mao, K., Xu, X., & Liang, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070037 · Cited by 285 · see citing works

Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect

Iliskovic, N., Hill, M. D., Chow, D. A., & Singal, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.10 · Cited by 282 · see citing works

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.

Siveski-Iliskovic, N., Kaul, N., & Singal, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.6.2829 · Cited by 268 · see citing works

Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo

Sun, W., Lee, T., Zhu, M., Gu, C., Wang, Y., Zhu, Y., & Shyy, J. Y.-J. (2006) · Circulation · doi:10.1161/circulationaha.106.630194 · Cited by 264 · see citing works

Epigenetics: interaction of DNA methylation and chromatin

Nakao, M. (2001) · Gene · doi:10.1016/s0378-1119(01)00721-1 · Cited by 251 · see citing works

Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy

Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 244 · see citing works

Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells

Shan, Y. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00229-3 · Cited by 235 · see citing works

Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention

Horenstein, M. S., Heide, R. S. V., & L’Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 231 · see citing works

Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway

Zhu, W., Soonpaa, M. H., Chen, H., Shen, W., Payne, R. M., Liechty, E. A., Caldwell, R. L., Shou, W., & Field, L. J. (2008) · Circulation · doi:10.1161/circulationaha.108.799700 · Cited by 229 · see citing works

New anthracycline antibiotics.

OKI, T. (1977) · PubMed · Cited by 227 · see citing works

Doxorubicin-induced Apoptosis Is Associated with Increased Transcription of Endothelial Nitric-oxide Synthase

Kalivendi, S. V., Kotamraju, S., Zhao, H., Joseph, J., & Kalyanaraman, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106829200 · Cited by 225 · see citing works

Updates in Anthracycline-Mediated Cardiotoxicity

Nebigil, C. G., & Désaubry, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01262 · Cited by 219 · see citing works

Intravenous administration of mitochondria for treating experimental Parkinson's disease

Shi, X., Zhao, M., Fu, C., & Fu, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.02.005 · Cited by 218 · see citing works

Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway

Horie, T., Ono, K., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Kuwabara, Y., Nakashima, Y., Takanabe‐Mori, R., Nishi, E., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq148 · Cited by 208 · see citing works

Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium

Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005) · Biochemical Journal · doi:10.1042/bj20050285 · Cited by 207 · see citing works

Malate dehydrogenase isoenzymes: Cellular locations and role in the flow of metabolites between the cytoplasm and cell organelles

Gietl, C. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0167-4838(92)90476-t · Cited by 205 · see citing works

Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment

Raj, S., Franco, V. I., & Lipshultz, S. E. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0315-4 · Cited by 200 · see citing works

Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.

Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., & Cairo, G. (2001) · PubMed · Cited by 199 · see citing works

New signal transduction paradigms in anthracycline-induced cardiotoxicity

Ghigo, A., Li, M., & Hirsch, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.021 · Cited by 196 · see citing works

miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation

Li, Z., Song, Y., Liu, L., Hou, N., An, X., Zhan, D., Li, Y., Zhou, L., Li, P., Yu, L., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.95 · Cited by 192 · see citing works

Doxorubicin Induces Apoptosis by Activation of Caspase-3 in Cultured Cardiomyocytes In Vitro and Rat Cardiac Ventricles In Vivo

Ueno, M., Kakinuma, Y., Yuhki, K., Murakoshi, N., Iemitsu, M., Miyauchi, T., & Yamaguchi, I. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050980 · Cited by 189 · see citing works

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Timm, K. N., & Tyler, D. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06941-x · Cited by 189 · see citing works

Effects by doxorubicin on the myocardium are mediated by oxygen free radicals

Xu, M. F., Tang, P. L., Qian, Z., & Ashraf, M. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00990-5 · Cited by 186 · see citing works

Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner

Yu, W., Qin, X., Zhang, Y., Qiu, P., Wang, L., Zha, W., & Ren, J. T. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-19-707 · Cited by 183 · see citing works

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase

SPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.009 · Cited by 182 · see citing works

Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats

Rajadurai, M., & Prince, P. S. M. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.053 · Cited by 180 · see citing works

Basic concepts of epigenetics

Inbar‐Feigenberg, M., Choufani, S., Butcher, D. T., Roifman, M., & Weksberg, R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.117 · Cited by 179 · see citing works

Extracellular Heat Shock Protein 60, Cardiac Myocytes, and Apoptosis

Kim, S.-C., Stice, J. P., Chen, L., Jung, J. S., Gupta, S., Wang, Y., Baumgarten, G., Trial, J., & Knowlton, A. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209643 · Cited by 179 · see citing works

Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity

Fan, G., Zhou, X., Wang, X., Song, G., Qian, J., Nicolaou, P. A., Chen, G., Ren, X., & Kranias, E. G. (2008) · Circulation Research · doi:10.1161/circresaha.108.182832 · Cited by 178 · see citing works

Mitochondrial catastrophe during doxorubicin‐induced cardiotoxicity: a review of the protective role of melatonin

Govender, J., Loos, B., Marais, E., & Engelbrecht, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12176 · Cited by 177 · see citing works

Conditional Cardiac Overexpression of Endothelin-1 Induces Inflammation and Dilated Cardiomyopathy in Mice

Yang, L. L., Gros, R., Kabir, M. G., Sadi, A.-M., Gotlieb, A. I., Husain, M., & Stewart, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000105701.98663.d4 · Cited by 177 · see citing works

The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium

Minotti, G., Recalcati, S., Mordente, A., Liberi, G., Calafiore, A. M., Mancuso, C., Preziosi, P., & Cairo, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.7.541 · Cited by 172 · see citing works

Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies

Ky, B., Vejpongsa, P., Yeh, E. T. H., Force, T. L., & Moslehi, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300218 · Cited by 171 · see citing works

Anticancer property of ginsenoside Rh2 from ginseng

Li, X., Chu, S., Lin, M., Gao, Y., Liu, Y., Yang, S., Zhou, X., Zhang, Y., Hu, Y., Wang, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112627 · Cited by 170 · see citing works

Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin

Miranda, C. J., Makui, H., Soares, R., Bilodeau, M., Mui, J., Vali, H., Bertrand, R., Andrews, N. C., & Santos, M. M. (2003) · Blood · doi:10.1182/blood-2003-03-0869 · Cited by 168 · see citing works

Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

Abdel‐Daim, M. M., Kilany, O. E., Khalifa, H. A., & Ahmed, A. A. M. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3413-7 · Cited by 166 · see citing works

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

Das, A., Durrant, D., Mitchell, C., Mayton, E. K., Hoke, N. N., Salloum, F. N., Park, M. A., Qureshi, I. Z., Lee, R., Dent, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006965107 · Cited by 160 · see citing works

Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission

Liang, X., Wang, S., Wang, L., Ceylan, A. F., Ren, J. T., & Zhang, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104846 · Cited by 160 · see citing works

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Tatlıdede, E., Şehırlı, Ö., Velioğlu‐Öğünç, A., Çetınel, Ş., Yeğen, B. Ç., Yarat, A., Süleymanoğlu, S., & Şener, G. (2009) · Free Radical Research · doi:10.1080/10715760802673008 · Cited by 156 · see citing works

Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis

Dargani, Z. T., & Singla, D. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00056.2019 · Cited by 153 · see citing works

Differential roles of caspase-1 and caspase-11 in infection and inflammation

Man, S. M., Karki, R., Briard, B., Burton, A. R., Gingras, S., Pelletier, S. W., & Kanneganti, T. (2017) · Scientific Reports · doi:10.1038/srep45126 · Cited by 152 · see citing works

LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy

Xia, Y., Chen, Z., Chen, A., Fu, M., Dong, Z., Hu, K., Yang, X., Zou, Y., Sun, A., Qian, J., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.06.003 · Cited by 146 · see citing works

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase

Liu, Y., Asnani, A. H., Zou, L., Bentley, V. L., Yu, M., Wang, Y., Dellaire, G., Sarkar, K. S., Dai, M. S., Chen, H. H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010189 · Cited by 139 · see citing works

NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis

Gilleron, M., Marechal, X., Montaigne, D., Franczak, J., Nevière, R., & Lancel, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.085 · Cited by 139 · see citing works

Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy

Bartlett, J. J., Trivedi, P. C., Yeung, P. K. F., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochemical Journal · doi:10.1042/bcj20160385 · Cited by 137 · see citing works

Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex

Gutteridge, J. M. C. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90340-x · Cited by 133 · see citing works

Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/ NADPH oxidase

Elnakish, M. T., Hassanain, H. H., Janssen, P. M. L., Angelos, M. G., & Khan, M. (2013) · The Journal of Pathology · doi:10.1002/path.4255 · Cited by 133 · see citing works

Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways

Ma, J., Wang, Y., Zheng, D., Meng, W., Xu, H., & Peng, T. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs309 · Cited by 132 · see citing works

Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy

Carvalho, R. A., Sousa, R. P. B., Cadete, V. J. J., Lopaschuk, G. D., Palmeira, C. M., Bjork, J. A., & Wallace, K. B. (2010) · Toxicology · doi:10.1016/j.tox.2010.01.019 · Cited by 131 · see citing works

Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor

Gharanei, M., Hussain, A., Janneh, O., & Maddock, H. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077713 · Cited by 130 · see citing works

Renal erythropoietin-producing cells in health and disease

Souma, T., Suzuki, N., & Yamamoto, M. P. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00167 · Cited by 128 · see citing works

Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A

Rayner, K. J., Chen, Y.-X., McNulty, M. S., Simard, T., Zhao, X., Wells, D. J., de Belleroche, J., & O’Brien, E. R. (2008) · Circulation Research · doi:10.1161/circresaha.108.172155 · Cited by 128 · see citing works

Doxorubicin treatment in vivo activates caspase‐12 mediated cardiac apoptosis in both male and female rats

Jang, Y. M., Kendaiah, S., Drew, B., Phillips, T., Selman, C., Julian, D. A., & Leeuwenburgh, C. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.053 · Cited by 126 · see citing works

Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study

Kobashigawa, L. C., Xu, Y. C., Padbury, J. F., Tseng, Y., & Yano, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104888 · Cited by 125 · see citing works

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis

Roca-Alonso, L., Castellano, L., Mills, A. M., Dabrowska, A. F., Sikkel, M. B., Pellegrino, L., Jacob, J., Frampton, A. E., Krell, J., Coombes, R. C., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.89 · Cited by 120 · see citing works

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy

Xu, H., Yu, W., Sun, S., Li, C., Zhang, Y., & Ren, J. T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00113 · Cited by 120 · see citing works

Pharmacokinetics of anticancer agents in patients with impaired liver function

Donelli, M. G., Zucchetti, M., Munzone, E., D’Incalci, M., & Crosignani, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00340-7 · Cited by 119 · see citing works

Activation of AMP-Activated Protein Kinase Contributes to Doxorubicin-Induced Cell Death and Apoptosis in Cultured Myocardial H9c2 Cells

Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 117 · see citing works

Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms

Xu, Z., Lin, S., Wu, W.-K., Tan, H., Wang, Z., Cheng, C., Lu, L., & Zhang, X. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.018 · Cited by 115 · see citing works

Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH

Deng, S., Kruger, A., Kleschyov, A. L., Kalinowski, L., Daiber, A., & Wojnowski, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.013 · Cited by 110 · see citing works

The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy

Bien, S., Riad, A., Ritter, C. A., Gratz, M., Olshausen, F., Westermann, D., Grube, M., Krieg, T., Ciecholewski, S., Felix, S. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1344 · Cited by 110 · see citing works

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients

Ruggeri, C., Gioffré, S., Achilli, F., Colombo, G. I., & D’Alessandra, Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9653-0 · Cited by 105 · see citing works

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2

Tong, Z., Jiang, B., Wu, Y., Liu, Y., Li, Y., Gao, M., Jiang, Y., Lv, Q., & Xiao, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714511 · Cited by 102 · see citing works

Impact of Frequency of Multi-Vitamin/Multi-Mineral Supplement Intake on Nutritional Adequacy and Nutrient Deficiencies in U.S. Adults

Blumberg, J., Frei, B., Fulgoni, V., Weaver, C., & Zeisel, S. (2017) · Nutrients · doi:10.3390/nu9080849 · Cited by 99 · see citing works

Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs

Jeong, S., Kim, H. K., Song, I.-S., Lee, S., Ko, K. S., Rhee, B. D., Kim, N., Mishchenko, N. P., Fedoryev, S., Stonik, V. A., et al. (2014) · Marine Drugs · doi:10.3390/md12052922 · Cited by 96 · see citing works

5-FU induced cardiotoxicity: case series and review of the literature

Yuan, C., Parekh, H. D., Allegra, C. J., George, T. J., & Starr, J. S. (2019) · Cardio-Oncology · doi:10.1186/s40959-019-0048-3 · Cited by 95 · see citing works

Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment

Vacchi‐Suzzi, C., Bauer, Y., Berridge, B. R., Bongiovanni, S., Gerrish, K., Hamadeh, H. K., Letzkus, M., Lyon, J. J., Moggs, J. G., Paules, R. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040395 · Cited by 94 · see citing works

Anthracycline Antibiotics

Fujiwara, A., Hoshino, T., & WESTLEY, J. W. (1985) · Critical Reviews in Biotechnology · doi:10.3109/07388558509150782 · Cited by 92 · see citing works

Resveratrol in prostate diseases - a short review

Jasiński, M., Jasińska, L., & Ogrodowczyk, M. (2013) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2013.02.art8 · Cited by 86 · see citing works

L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations.

Keung, E. C., Toll, L., Ellis, M., & Jensen, R. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115241 · Cited by 86 · see citing works

PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades

Liu, D., Ma, Z., Xu, L., Zhang, X., Qiao, S., & Yuan, J. (2019) · Aging · doi:10.18632/aging.102418 · Cited by 86 · see citing works

The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity

Ayza, M. A., Zewdie, K. A., Tesfaye, B. A., Wondafrash, D. Z., & Berhe, A. H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4965171 · Cited by 78 · see citing works

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity

Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 77 · see citing works

MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction

Tony, H., Yu, K., & Qiutang, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/597032 · Cited by 76 · see citing works

p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury

Velez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T. J., Plabplueng, C. D., Oberley, T. D., Jungsuwadee, P., Remmen, H. V., Vore, M. E., & Clair, D. K. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018005 · Cited by 73 · see citing works

Doxorubicin-Induced Cardiotoxicity: From Mechanisms to Development of Efficient Therapy

dos Santos, D. S., & Goldenberg, R. C. D. S. (2018) · InTech eBooks · doi:10.5772/intechopen.79588 · Cited by 70 · see citing works

Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice

Vedam, K., Nishijima, Y., Druhan, L. J., Khan, M., Moldovan, N. I., Zweier, J. L., & Ilangovan, G. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01047.2009 · Cited by 69 · see citing works

HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation

Song, R. Y., Yang, Y., Han, L., Wang, G., Huang, Y. C., Xue, W., Wang, Y., Yao, L., & Zhu, Y. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.10.007 · Cited by 69 · see citing works

Interaction of anthracyclines with iron responsive element mRNAs

Canzoneri, J. C., & Oyelere, A. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn774 · Cited by 65 · see citing works

Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle

Nielsen, T. T., Støttrup, N. B., Løfgren, B., & Bøtker, H. E. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr051 · Cited by 64 · see citing works

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation

Lü, J., Li, J., Hu, Y., Guo, Z., Sun, D., Wang, P., Guo, K., Duan, D. D., Gao, S., Jiang, J., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.008 · Cited by 64 · see citing works

Telomerase therapy attenuates cardiotoxic effects of doxorubicin

Chatterjee, S., Hofer, T., Costa, A., Lu, D., Batkai, S., Gupta, S. K., Bolesani, E., Zweigerdt, R., Megias, D., Streckfuss-Bömeke, K., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.035 · Cited by 63 · see citing works

Regulation of Rac1 by Simvastatin in Endothelial Cells

Kou, R., Sartoretto, J. L., & Michel, T. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808664200 · Cited by 62 · see citing works

Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo

Wang, H., Yu, P., Gou, H., Zhang, J., Zhu, M. J., Wang, Z., Tian, J., Jiang, Y., & Fu, F. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/506214 · Cited by 60 · see citing works

Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-κB activation

Kim, D., Woo, E., Chae, S., Ha, K.-C., Lee, G., Hong, S., Kwon, D., Kim, M., Jung, Y., Kim, H., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.019 · Cited by 60 · see citing works

CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression

Tscheschner, H., Meinhardt, E., Schlegel, P., Jungmann, A., Lehmann, L., Müller, O. J., Most, P., Katus, H. A., & Raake, P. W. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215992 · Cited by 60 · see citing works

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial

Engert, A., Josting, A., Haverkamp, H., Villalobos, M., Lohri, A., Sökler, M., Zijlstra, J. M., Sturm, I., Topp, M. S., Rank, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1835 · Cited by 57 · see citing works

Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion‐associated cardiac arrhythmias

Lekli, I., Haines, D. D., Balla, G., & Tósaki, Á. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13053 · Cited by 56 · see citing works

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

Xu, Y., Liu, Z., Sun, J., Pan, Q., Sun, F., Yan, Z., & Hu, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028335 · Cited by 55 · see citing works

Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin‐Induced Heart Failure Through Resolution of Toll‐Like Receptor 2–Mediated Myocardial Inflammation

Liu, P., Bao, H., Jin, C., Zhou, J., Hua, F., Li, K., Lv, X., Cui, B., Hu, Z., & Zhang, X. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012338 · Cited by 55 · see citing works

Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats

Karabulut, D., Öztürk, E., Kaymak, E., Akın, A. T., & Yakan, B. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22618 · Cited by 55 · see citing works

An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity

Beak, J. Y., Huang, W., Parker, J. S., Hicks, S. T., Patterson, C., Simpson, P. C., Ma, A., Jin, J. J., & Jensen, B. C. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.10.006 · Cited by 54 · see citing works

Chia Seed Oil Ameliorates Doxorubicin-Induced Cardiotoxicity in Female Wistar Rats: An Electrocardiographic, Biochemical and Histopathological Approach

Ahmed, A. Z., Mumbrekar, K. D., Satyam, S. M., Shetty, P., D’Souza, M. R., & Singh, V. K. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09644-3 · Cited by 54 · see citing works

Schisandrin B Prevents Doxorubicin-Induced Cardiotoxicity via Enhancing Glutathione Redox Cycling

Li, L., Pan, Q., Han, W., Liu, Z., Li, L., & Hu, X. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1579 · Cited by 53 · see citing works

Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases

Akolkar, G., Bagchi, A. K., Ayyappan, P., Jassal, D. S., & Singal, P. K. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2016 · Cited by 52 · see citing works

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2

McLaughlin, D., Zhao, Y., O’Neill, K. M., Edgar, K. S., Dunne, P. D., Kearney, A. M., Grieve, D., & McDermott, B. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13773 · Cited by 52 · see citing works

Proanthocyanidin alleviates doxorubicin‐induced cardiac injury by inhibiting NF‐ k B pathway and modulating oxidative stress, cell cycle, and fibrogenesis

Sadek, K. M., Mahmoud, S. F. E., Zeweil, M. F., & Abouzed, T. K. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22716 · Cited by 52 · see citing works

Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress

Ahmed, A. Z., Satyam, S. M., Shetty, P., & D’Souza, M. R. (2021) · Scientifica · doi:10.1155/2021/6694340 · Cited by 52 · see citing works

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity

Kumari, H., Huang, W.-H., & Chan, M. W. Y. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00056 · Cited by 51 · see citing works

Management of Blood Cholesterol

Alenghat, F. J., & Davis, A. M. (2019) · JAMA · doi:10.1001/jama.2019.0015 · Cited by 50 · see citing works

A new insight into adriamycin-induced cardiotoxicity

Fu, L.-X., Waagstein, F., & Hjalmarson, A. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90267-9 · Cited by 49 · see citing works

The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity

Blanter, J., & Frishman, W. H. (2019) · Cardiology in Review · doi:10.1097/crd.0000000000000252 · Cited by 48 · see citing works

Transfusion Iron Overload in Adults with Acute Leukemia: Manifestations and Therapy

Barton, J. C., & Bertoli, L. F. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40691-3 · Cited by 46 · see citing works

Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways

Alzahrani, A. M., Rajendran, P., Veeraraghavan, V. P., & Hanieh, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063269 · Cited by 46 · see citing works

Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues

Kashfi, K., Israel, M., Sweatman, T. W., Seshadri, R., & Cook, G. A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90438-q · Cited by 45 · see citing works

Natural Products and Drug Discovery

(2018) · Elsevier eBooks · doi:10.1016/c2016-0-02061-2 · Cited by 44 · see citing works

Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress

Zhao, D., Xue, C., Li, J., Feng, K., Zeng, P., Chen, Y., Duan, Y., Zhang, S., Li, X., Han, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.035 · Cited by 44 · see citing works

Hydrogen sulfide ameliorates doxorubicin‑induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway

Nie, L., Liu, M., Chen, J., Wu, Q., Li, Y., Yi, J., Zheng, X., Zhang, J., Chu, C., & Yang, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11938 · Cited by 44 · see citing works

Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice

Tanaka, Y., Nagoshi, T., Yoshii, A., Oi, Y., Takahashi, H., Kimura, H., Ito, K., Kashiwagi, Y., Tanaka, T. D., & Yoshimura, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.303 · Cited by 43 · see citing works

Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage

Yang, G., Song, M., Hoang, D. H., Tran, Q. H., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00541-3 · Cited by 43 · see citing works

Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig

Goetzenich, A., Hatam, N., Zernecke, A., Weber, C., Czarnotta, T., Autschbach, R., & Christiansen, S. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.06.025 · Cited by 42 · see citing works

Heat Shock Protein 22 Attenuates Doxorubicin-Induced Cardiotoxicity via Regulating Inflammation and Apoptosis

Yin, L., Wang, Y., Huang, K., & Zeng, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00257 · Cited by 42 · see citing works

Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats

Liu, B., Li, H., Qu, H., & Sun, B. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.759 · Cited by 40 · see citing works

Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies

Yang, Y., & Bu, P. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.08.006 · Cited by 37 · see citing works

Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition

Fan, X., Elkin, K. B., Shi, Y., Zhang, Z., Cheng, Y., Gu, J., Liang, J., Wang, C., & Ji, X. (2020) · Neurological Research · doi:10.1080/01616412.2020.1782079 · Cited by 37 · see citing works

Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway

Zhang, L., Feng, M., Wang, X., Zhang, H., Ding, J., Cheng, Z., & Qian, L. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4896 · Cited by 37 · see citing works

Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention

Csapo, M., & Lazăr, L. (2014) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-339 · Cited by 36 · see citing works

Anthracycline Cardiotoxicity

Menna, P., Salvatorelli, E., Gianni, L., & Minotti, G. (2007) · Topics in current chemistry · doi:10.1007/128_2007_11 · Cited by 34 · see citing works

METABOLISM OF THE ONE-RING OPEN METABOLITES OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE TO ITS ACTIVE METAL-CHELATING FORM IN THE RAT

Schroeder, P. E., & Hasinoff, B. B. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005546 · Cited by 33 · see citing works

Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible

Hawkes, E. A., Okines, A. F. C., Plummer, C., & Cunningham, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5008 · Cited by 33 · see citing works

Curcumin Attenuates Doxorubicin-Induced Cardiotoxicity by Inducing Autophagy via the Regulation of JNK Phosphorylation

Katamura, M. (2014) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000337 · Cited by 30 · see citing works

Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature

Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 30 · see citing works

New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity

El‐Demerdash, E., Ali, A. A., Sayed‐Ahmed, M. M., & Osman, A. M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0676-y · Cited by 29 · see citing works

Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity

An, J., & Sheikh, M. S. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009618666171129222159 · Cited by 29 · see citing works

Protective Effect of Two Alkaloids from Hippophae rhamnoides Linn. against Doxorubicin-Induced Toxicity in H9c2 Cardiomyoblasts

Zhou, W., Ouyang, J., Hu, N., Li, G., & Wang, H. (2021) · Molecules · doi:10.3390/molecules26071946 · Cited by 29 · see citing works

Drug Induced Cardiotoxicity: Mechanism, Prevention and Management

Kelleni, M. T., & Abdelbasset, M. (2018) · InTech eBooks · doi:10.5772/intechopen.79611 · Cited by 28 · see citing works

Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity

Feng, K., Liu, Y., Sun, J. M., Zhao, C.-L., Duan, Y., Wang, W., Yan, K., Yan, X., Sun, H., Hu, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111531 · Cited by 28 · see citing works

MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway

Li, X., Zhong, J., Zeng, Z., Wang, H., Li, J., Liu, X., & Yang, X. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-490 · Cited by 27 · see citing works

[Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line].

Liu, B., Bai, Q.-X., Chen, X., Gao, G., & Gu, H. (2007) · PubMed · Cited by 24 · see citing works

Xinmailong Attenuates Doxorubicin‐Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO‐1

Jiang, Y., Liu, Y., Xiao, W. H., Zhang, D., Liu, X., Xiao, H., You, S., & Yuan, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5896931 · Cited by 24 · see citing works

Protective effects of pyrrolidine dithiocarbamate on myocardium apoptosis induced by adriamycin in rats

Li, H., Gu, H.-Y., & Sun, B. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.01.010 · Cited by 22 · see citing works

Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats

Zhan, C., Bai, N., Zheng, M., Wang, Y., Wang, Y., Zhang, L., Li, J., Li, G., Zhao, H., Liu, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118984 · Cited by 22 · see citing works

Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts

Ramond, A., Sartorius, E., Mousseau, M., Ribuot, C., & Joyeux‐Faure, M. (2008) · Experimental Biology and Medicine · doi:10.3181/0706-rm-152 · Cited by 21 · see citing works

Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose Doxorubicin

Salvatorelli, E., Menna, P., Chello, M., Covino, E., & Minotti, G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242388 · Cited by 21 · see citing works

Diagnosis of Chemotherapy-Induced Cardiotoxicity

Pizzino, F., Vizzari, G., Bomzer, C. A., Qamar, R., Carerj, S., Zito, C., & Khandheria, B. K. (2014) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1025 · Cited by 20 · see citing works

Human neuronal nitric oxide synthase can catalyze one-electron reduction of adriamycin: role of flavin domain

Fu, J., Yamamoto, K., Guan, Z., Kimura, S., & Iyanagi, T. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.030 · Cited by 20 · see citing works

Curcumin

Shehzad, A., Shahzad, R., & Lee, Y. S. (2014) · The Enzymes · doi:10.1016/b978-0-12-802215-3.00008-2 · Cited by 20 · see citing works

Role of Oxidation‐Dependent CaMKII Activation in the Genesis of Abnormal Action Potentials in Atrial Cardiomyocytes: A Simulation Study

Zhao, N., Li, Q., Sui, H., & Zhang, H. (2020) · BioMed Research International · doi:10.1155/2020/1597012 · Cited by 19 · see citing works

In vivo studies on adriamycin-induced lipid peroxidation and effects of ferrous ions.

Kappus, H., Muliawan, H., & Scheulen, M. E. (1980) · PubMed · Cited by 15 · see citing works

Possible protective effects of quercetin on doxorubicin-induced cardiotoxicity in rats

Hashish, F. R., Abdel-Wahed, M. M., Odemi, M. E., El-Naidany, S., & ElBatsh, M. M. (2021) · Menoufia Medical Journal · doi:10.4103/mmj.mmj_5_20 · Cited by 15 · see citing works

Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration

Haug, K. G., Weber, B., Hochhaus, G., & Butterweck, V. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.023 · Cited by 13 · see citing works

Development of Chinese Herbal Health Products for the Prevention of Aging-Associated Diseases

Leong, P. K., Chen, J., & Ko, K. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-102081-4.00004-6 · Cited by 10 · see citing works

Cardioprotective effect of Malva verticillata against doxorubicin -induced toxicity in rats

Ibrahim, D. A., Almutawakel, M. A., & Albadani, R. N. (2021) · Clinical Phytoscience · doi:10.1186/s40816-021-00265-5 · Cited by 8 · see citing works

Research Methodologies and Practical Applications of Chemistry

Pogliani, L., Haghi, A. K., & Islam, N. (2019) · Apple Academic Press eBooks · doi:10.1201/9780429023460 · Cited by 6 · see citing works

Pharmacokinetics of Doxorubicin In Normal Weight and Obese Lymphoma Patients

Hoffmann, M. F., Bergner, R., Stützle, M., Uppenkamp, M. J., & Foerster, R. (2010) · Blood · doi:10.1182/blood.v116.21.4935.4935 · Cited by 3 · see citing works

Calycosin-triblock copolymer nanomicelles attenuate doxorubicin-induced cardiotoxicity through upregulation of ERp57

Wang, X., Zeng, L., Tu, S., Ye, F., & Zhang, Z. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103142 · Cited by 3 · see citing works

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska‐Kołat, Ż., Çeli̇k, İ., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 864 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

Gene therapy: Comprehensive overview and therapeutic applications

Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120375 · Cited by 352 · see citing works

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches

Sheibani, M., Azizi, Y., Shayan, M., Nezamoleslami, S., Eslami, F., Farjoo, M. H., & Dehpour, A. R. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09721-1 · Cited by 281 · see citing works

Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity

Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. T. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 259 · see citing works

A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging

Linders, A. N., Dias, I. B., López‐Fernández, T., Tocchetti, C. G., Bömer, N., & van der Meer, P. (2024) · npj Aging · doi:10.1038/s41514-024-00135-7 · Cited by 257 · see citing works

Anthracycline Cardiotoxicity in Adult Cancer Patients

Camilli, M., Cipolla, C. M., Dent, S. F., Minotti, G., & Cardinale, D. M. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.016 · Cited by 250 · see citing works

Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis

Zhang, S., Liu, Q., Chang, M., Pan, Y. H., Yahaya, B. H., Liu, Y., & Lin, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05859-0 · Cited by 208 · see citing works

Mitochondrial quality control in human health and disease

Liu, B., Xu, C.-Z., Liu, Y., Lu, Z., Fu, T.-L., Li, G., Deng, Y., Luo, G., Ding, S. Z., Li, N., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00536-5 · Cited by 189 · see citing works

Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer

Khan, M. S., Gowda, B. H. J., Nasir, N., Wahab, S., Pichika, M. R., Sahebkar, A., & Kesharwani, P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123276 · Cited by 154 · see citing works

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Lee, J., Choi, M., & Song, I. (2023) · Pharmaceuticals · doi:10.3390/ph16060802 · Cited by 134 · see citing works

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles

Hu, Y., Liu, Y., Zong, L., Zhang, W., Liu, R., Xing, Q., Liu, Z., Yan, Q., Li, W., Lei, H., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06382-y · Cited by 127 · see citing works

Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy

Chen, Y., Shi, S., & Dai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113903 · Cited by 123 · see citing works

Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account

Vitale, R., Marzocco, S., & Popolo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137477 · Cited by 122 · see citing works

Doxorubicin-induced cardiotoxicity and risk factors

Belger, C., Abrahams, C., Imamdin, A., & Lecour, S. (2023) · International Journal of Cardiology: Heart & Vasculature · doi:10.1016/j.ijcha.2023.101332 · Cited by 113 · see citing works

Anticancer potential of allicin: A review

Catanzaro, E., Canistro, D., Pellicioni, V., Vivarelli, F., & Fimognari, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106118 · Cited by 115 · see citing works

Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1/Nrf2 pathway

Zhang, W., Wang, X., Tang, Y., & Huang, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114591 · Cited by 94 · see citing works

Nrf2: a dark horse in doxorubicin-induced cardiotoxicity

Zhao, X., Tian, Z., Sun, M., & Dong, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01565-0 · Cited by 93 · see citing works

Silver nanoparticle based multifunctional approach for combating COVID-19

Allawadhi, P., Singh, V., Khurana, A., Khurana, I., Allwadhi, S., Kumar, P., Banothu, A. K., Thalugula, S., Barani, P. J., Naik, R. R., et al. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100101 · Cited by 92 · see citing works

Quinones as Neuroprotective Agents

Cores, Á., Carmona-Zafra, N., Clerigué, J., Villacampa, M., & Menéndez, J. C. (2023) · Antioxidants · doi:10.3390/antiox12071464 · Cited by 92 · see citing works

Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases

Zhou, Z., Li, M., Zhang, Z., Song, Z., Xu, J., Zhang, M., & Gong, M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118506 · Cited by 90 · see citing works

Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model

Dulf, P. L., Mocan, M., Coadǎ, C. A., Dulf, D. V., Moldovan, R., Bâldea, I., Fărcaș, A. D., Blendea, D. C., & Filip, G. A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02382-z · Cited by 85 · see citing works

Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance

Gong, J., Shi, T., Liu, J., Pei, Z., Liu, J., Ren, X., Li, F., & Qiu, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114505 · Cited by 82 · see citing works

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice

Lérida‐Viso, A., Estepa‐Fernández, A., Morellá‐Aucejo, Á., Lozano‐Torres, B., Alfonso, M., Blandez, J. F., Bisbal, V., Sepúlveda, P., García‐Fernández, A., Orzáez, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106356 · Cited by 80 · see citing works

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer

Rocca, C., Soda, T., Francesco, E. D. D., Fiorillo, M., Moccia, F., Viglietto, G., Angelone, T., & Amodio, N. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04498-5 · Cited by 82 · see citing works

Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity

Ye, C., Chen, Y., Bian, S.-J., Li, X., Li, Y., Wang, K., Zhu, Y., Wang, L., Wang, Y., Wang, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02705-z · Cited by 78 · see citing works

Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway

Chen, D., Yu, W., Zhong, C., Hong, Q., Huang, G., Que, D., Wang, Y., Yang, Y., Rui, B., Zhuang, Z., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106186 · Cited by 75 · see citing works

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention

Qiu, Y., Jiang, P., & Huang, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1242596 · Cited by 74 · see citing works

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update

Bhutani, V., Varzideh, F., Wilson, S. M., Kansakar, U., Jankauskas, S. S., & Santulli, G. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12060207 · Cited by 74 · see citing works

Doxorubicin-loaded micelles in tumor cell-specific chemotherapy

Almajidi, Y. Q., Kadhim, M. M., Alsaikhan, F., Jalil, A. T., Sayyid, N. H., Ramírez‐Coronel, A. A., Jawhar, Z. H., Gupta, J., Nabavi, N., Yu, W., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115722 · Cited by 72 · see citing works

pH-Responsive Chitosan-Adorned Niosome Nanocarriers for Co-Delivery of Drugs for Breast Cancer Therapy

Karimifard, S., Rezaei, N., Jamshidifar, E., Langeroodi, S. M. F., Abdihaji, M., Mansouri, A., Hosseini, M., Ahmadkhani, N., Rahmati, Z., Heydari, M., et al. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c00861 · Cited by 71 · see citing works

Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway

Chen, L., Sun, X., Wang, Z., Chen, M., He, Y., Zhang, H., Han, D., & Zheng, L. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116794 · Cited by 69 · see citing works

Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity

Wu, L., Zhang, Y., Wang, G., & Ren, J. T. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.10.009 · Cited by 68 · see citing works

Esculetin improves inflammation of the kidney via gene expression against doxorubicin-induced nephrotoxicity in rats: In vivo and in silico studies

Karağaç, M. S., Yeşilkent, E. N., Kizir, D., Öztürk, N., Isıyel, M., Karadaş, H., Tosun, H., Karaman, M., Ceylan, H., & Demir, Y. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105159 · Cited by 65 · see citing works

The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity

Bhagat, A., Shrestha, P., & Kleinerman, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314649 · Cited by 64 · see citing works

Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment

Fabiani, I., Chianca, M., Cipolla, C. M., & Cardinale, D. M. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01126-1 · Cited by 63 · see citing works

Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy

Sharafshadeh, M. S., Tafvizi, F., Khodarahmi, P., & Ehtesham, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123686 · Cited by 61 · see citing works

Bento: a toolkit for subcellular analysis of spatial transcriptomics data

Mah, C. K., Ahmed, N., Lopez, N. A., Lam, D. C., Pong, A., Monell, A., Kern, C., Han, Y., Prasad, G., Cesnik, A. J., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03217-7 · Cited by 59 · see citing works

Promising influences of caffeic acid and caffeic acid phenethyl ester against natural and chemical toxins: A comprehensive and mechanistic review

Ehtiati, S., Alizadeh, M., Farhadi, F., Khalatbari, K., Ajiboye, B. O., Rahimi, V. B., & Askari, V. R. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105637 · Cited by 58 · see citing works

Allium sativum derived carbon dots as a potential theranostic agent to combat the COVID-19 crisis

Kalkal, A., Allawadhi, P., Pradhan, R., Khurana, A., Bharani, K. K., & Packirisamy, G. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100102 · Cited by 57 · see citing works

Recent progress in tannic acid based approaches as a natural polyphenolic biomaterial for cancer therapy: A review

Ghasemian, M., Kazeminava, F., Naseri, A., Mohebzadeh, S., Abbaszadeh, M., Kafil, H. S., & Ahmadian, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115328 · Cited by 55 · see citing works

A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating PI3K/AKT/mTOR-Mediated Autophagy in Cancer

Rahman, M. A., Jalouli, M., Bhajan, S. K., Al-Zharani, M. M., & Harrath, A. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051868 · Cited by 55 · see citing works

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

Adhikari, A., Asdaq, S. M. B., Hawaj, M. A. A., Chakraborty, M., Thapa, G., Bhuyan, N. R., Imran, M., Alshammari, M. K., Alshehri, M. M., Harshan, A. A., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14100970 · Cited by 55 · see citing works

TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation

Piciu, F., Balaș, M., Badea, M. A., & Cucu, D. (2023) · Antioxidants · doi:10.3390/antiox12071327 · Cited by 54 · see citing works

Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience

Jurgens, S. J., Rämö, J. T., Kramarenko, D. R., Wijdeveld, L. F. J. M., Haas, J., Chaffin, M. D., Garnier, S., Gaziano, L., Weng, L.-C. C., Lipov, A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01975-5 · Cited by 54 · see citing works

Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway

Hu, S., Liu, B., Yang, M., Mao, S., Ju, H., Liu, Z., Huang, M., & Wu, G. (2023) · Food & Function · doi:10.1039/d2fo03904d · Cited by 53 · see citing works

Impact of Exercise and Aging on Mitochondrial Homeostasis in Skeletal Muscle: Roles of ROS and Epigenetics

Li, J., Wang, Z., Li, C., Song, Y., Wang, Y., Hai, B., & Zhang, Y. (2022) · Cells · doi:10.3390/cells11132086 · Cited by 52 · see citing works

Common methods in mitochondrial research (Review)

Yin, Y., & Shen, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5182 · Cited by 52 · see citing works

Tumor micro-environment sensitive release of doxorubicin through chitosan based polymeric nanoparticles: An in-vitro study

Akram, M. U., Abbas, N., Farman, M. T., Manzoor, S., Khan, M. I., Osman, S. M., Luque, R., & Shanableh, A. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137332 · Cited by 52 · see citing works

ROS- and pH-Responsive Polydopamine Functionalized Ti3C2Tx MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity

Zhang, W., Li, S., Vijayan, V., Lee, J. S., Park, S. S., Cui, X., Chung, I., Lee, J., Ahn, S., Kim, J. R., et al. (2022) · Nanomaterials · doi:10.3390/nano12244392 · Cited by 52 · see citing works

Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties

Angulo-Elizari, E., Henriquez-Figuereo, A., Morán‐Serradilla, C., Plano, D., & Sanmartín, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116249 · Cited by 52 · see citing works

A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies

Youden, B., Jiang, R., Carrier, A. J., Servos, M. R., & Zhang, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c06337 · Cited by 51 · see citing works

Graphene-integrated mesh electronics with converged multifunctionality for tracking multimodal excitation-contraction dynamics in cardiac microtissues

Gao, H., Wang, Z., Yang, F., Wang, X., Wang, S., Zhang, Q., Liu, X., Sun, Y., Kong, J., & Yao, J. (2024) · Nature Communications · doi:10.1038/s41467-024-46636-7 · Cited by 50 · see citing works

Single-Walled Carbon Nanotubes as Optical Transducers for Nanobiosensors In Vivo

Cohen, Z. L., & Williams, R. M. (2024) · ACS Nano · doi:10.1021/acsnano.4c13076 · Cited by 48 · see citing works

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity

Lin, X., Wu, G., Wang, S., & Huang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1255158 · Cited by 47 · see citing works

Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice

Alzokaky, A. A., Al-Karmalawy, A. A., Saleh, M. A., Abdo, W., Farage, A. E., Belal, A., Abourehab, M. A. S., & Antar, S. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121390 · Cited by 46 · see citing works

Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

Pogorzelska, A., Mazur, M., Świtalska, M., Wietrzyk, J., Sigorski, D., Fronczyk, K., & Wiktorska, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114490 · Cited by 46 · see citing works

Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery

Dongsar, T. S., Dongsar, T. T., Molugulu, N., Annadurai, S., Wahab, S., Gupta, N., & Kesharwani, P. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116455 · Cited by 46 · see citing works

Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy

Bagdasaryan, A. A., Chubarev, V. N., Smolyarchuk, Е. А., Drozdov, V. N., Krasnyuk, I. I., Liu, J., Fan, R., Tse, E., Ших, Е. В., & Sukocheva, O. A. (2022) · Cancers · doi:10.3390/cancers14215436 · Cited by 45 · see citing works

A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy

Saharkhiz, S., Zarepour, A., Nasri, N., Cordani, M., & Zarrabi, A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106600 · Cited by 45 · see citing works

Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity

Zeng, Y., Liao, X., Guo, Y., Liu, F., Bu, F., Zhan, J., Zhang, J., Cai, Y., & Shen, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.034 · Cited by 45 · see citing works

Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action

Pharoah, B. M., Zhang, C., Khodade, V. S., Keceli, G., McGinity, C. L., Paolocci, N., & Toscano, J. P. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102625 · Cited by 43 · see citing works

Mitochondrial-derived peptides in cardiovascular disease: Novel insights and therapeutic opportunities

Li, Y., Li, Z., Ren, Y., Lei, Y., Yang, S., Shi, Y., Peng, H., Yang, W., Guo, T., Yu, Y., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.11.018 · Cited by 43 · see citing works

Mechanisms and Drug Intervention for Doxorubicin‐Induced Cardiotoxicity Based on Mitochondrial Bioenergetics

Ling, G., Wang, X., Tan, N., Cao, J., Li, W., Zhang, Y., Jiang, J., Sun, Q., Jiang, Y., Wang, W., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7176282 · Cited by 42 · see citing works

Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway

Zhong, Z., Gao, Y., Zhou, J., Wang, F., Zhang, P., Hu, S., Wu, H., Lou, H., Chi, J., Lin, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115654 · Cited by 42 · see citing works

Effects of cold atmospheric-pressure plasma in combination with doxorubicin drug against breast cancer cells in vitro and in vivo

Dezhpour, A., Ghafouri, H., Jafari, S., & Nilkar, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.10.405 · Cited by 43 · see citing works

Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway

Al-Kenany, S. A., & Al-Shawi, N. N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1206782 · Cited by 41 · see citing works

Progress of Nanomaterials-Based Photothermal Therapy for Oral Squamous Cell Carcinoma

Niu, Q., Sun, Q., Bai, R., Zhang, Y., Zhuang, Z., Zhang, X., Xin, T., Chen, S., & Han, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810428 · Cited by 40 · see citing works

Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity

Sumneang, N., Tanajak, P., & Oo, T. T. (2023) · Molecules · doi:10.3390/molecules28114294 · Cited by 40 · see citing works

Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers

Torres, J., Oses, J. K. V., Rabasco, A. M., González-Rodrı́guez, M. L., & García, M. C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020245 · Cited by 40 · see citing works

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments

Zhang, G., Yuan, C., Su, X., Zhang, J., Gokulnath, P., Vulugundam, G., Li, G., Yang, X., An, N., Liu, C., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.896792 · Cited by 40 · see citing works

Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical

Dong, R., Yan, Y., Zeng, X., Lin, N., & Tan, B. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s377697 · Cited by 39 · see citing works

Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity

Boen, H. M., Cherubin, M., Franssen, C., Gevaert, A. B., Witvrouwen, I., Bosman, M., Guns, P., Heidbüchel, H., Loeys, B., Alaerts, M., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.12.009 · Cited by 38 · see citing works

Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

Quagliariello, V., Canale, M. L., Bisceglia, I., Iovine, M., Paccone, A., Maurea, C., Scherillo, M., Merola, A., Giordano, V., Palma, G., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1289663 · Cited by 38 · see citing works

Theranostic magnetic nanoparticles enhance DNA damage and mitigate doxorubicin-induced cardio-toxicity for effective multi-modal tumor therapy

Shetake, N. G., Ali, M., Kumar, A., Bellare, J., & Pandey, B. N. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213147 · Cited by 38 · see citing works

Ginsenoside Rb1 attenuates doxorubicin induced cardiotoxicity by suppressing autophagy and Nrf2 induced ferroptosis

Zhai, Y., Bai, J., Peng, Y., Cao, J., Fang, G., Dong, Y., Wang, Z., Lu, Y., Wang, M., Liu, M., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149910 · Cited by 37 · see citing works

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes

Liu, D., Cheng, X., Wu, H., Song, H., Bu, Y., Wang, J., Zhang, X., Yan, C., & Han, Y. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103293 · Cited by 37 · see citing works

Y-Co metal-organic framework for sensitive electrochemical determination of doxorubicin hydrochloride

Mir, S., Torbati, N. A., Amani, V., Tajik, S., & Beitollahi, H. (2025) · ADMET & DMPK · doi:10.5599/admet.3141 · Cited by 37 · see citing works

Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma

Du, J., Sun, J., Liu, X., Wu, Q., Shen, W., Gao, Y., Liu, Y., & Wu, C. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106338 · Cited by 36 · see citing works

Alkaloids from Piper longum Exhibit Anti-inflammatory Activity and Synergistic Effects with Chemotherapeutic Agents against Cervical Cancer Cells

Wan, Q., Xu, J., Zhu, C., Liu, X., Tu, Y., Lei, J., & Yu, J. J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01667 · Cited by 36 · see citing works

Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD

Dai, S., Chen, Y., Fan, X., Han, J., Zhong, L., Zhang, Y., Liu, Q., Lin, J., Huang, W., Su, L., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155105 · Cited by 36 · see citing works

H2S Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity

Hu, Q., & Lukesh, J. C. (2023) · Antioxidants · doi:10.3390/antiox12030650 · Cited by 35 · see citing works

Disulfide-Cross-Linked Nanogel-Based Nanoassemblies for Chemotherapeutic Drug Delivery

Campea, M. A., Lofts, A., Xu, F., Yeganeh, M., Kostashuk, M., & Hoare, T. R. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c02575 · Cited by 35 · see citing works

Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening

Zhu, Y., Jiang, D., Qiu, Y. L., Liu, X., Bian, Y., Tian, S., Wang, X., Hsia, K. J., Wan, H., Zhuang, L., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.019 · Cited by 35 · see citing works

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity

Kuang, Z., Wu, J., Tan, Y. C., Zhu, G., Li, J., & Wu, M. (2023) · Biomolecules · doi:10.3390/biom13030568 · Cited by 34 · see citing works

Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling

Roberts, J. A., Rainbow, R. D., & Sharma, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076723 · Cited by 34 · see citing works

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems

Zhang, L., & Li, J. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01585-8 · Cited by 34 · see citing works

Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer

Ahmed, K. R., Rahman, M. M., Islam, M. N., Fahim, M. M. H., Rahman, M. A., & Kim, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116497 · Cited by 34 · see citing works

Spexin inhibits excessive autophagy‐induced ferroptosis to alleviate doxorubicin‐induced cardiotoxicity by upregulating Beclin 1

Ou, W., Liu, H., Chen, C., Yang, C., Zhao, X., Zhang, Y., Zhang, Z., Huang, S., Mo, H., Lu, W., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16484 · Cited by 34 · see citing works

Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?

Correia, C. D., Ferreira, A., Fernandes, M. T., Silva, B. M., Esteves, F., Leitão, H. S., Bragança, J., & Calado, S. M. (2023) · Cells · doi:10.3390/cells12131727 · Cited by 34 · see citing works

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy

Chang, X., Feng, X., Du, M., Li, S., Wang, J., Wang, Y., & Liu, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1194861 · Cited by 33 · see citing works

Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study

Maleki, F., Rabbani, S., Shirkoohi, R., & Rezaei, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115651 · Cited by 33 · see citing works

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity

Sobiborowicz, A., Kamińska, K., & Cudnoch‐Jędrzejewska, A. (2023) · Cancers · doi:10.3390/cancers15010312 · Cited by 33 · see citing works

Phototherapeutic nanoagents for cancer immunotherapy

He, M., Xiao, M., Wang, R., Fan, J., Peng, X., & Sun, W. C. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101347 · Cited by 32 · see citing works

Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches

Song, L., Qiu, Q., Ju, F., & Zheng, C. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110140 · Cited by 32 · see citing works

In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy

Quagliariello, V., Berretta, M., Bisceglia, I., Giacobbe, I., Iovine, M., Barbato, M., Maurea, C., Canale, M. L., Paccone, A., Inno, A., et al. (2025) · Cancers · doi:10.3390/cancers17071169 · Cited by 32 · see citing works

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity

Zhou, P., Gao, G., Zhao, C., Li, J., Peng, J.-F., Wang, S., Song, R., Shi, H. M., & Wang, L. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2046801 · Cited by 32 · see citing works

Scutellarin Attenuates Doxorubicin‐Induced Cardiotoxicity by Inhibiting Myocardial Fibrosis, Apoptosis and Autophagy in Rats

Sun, X., Zhou, L., Han, Y., Yang, Q., Li, X., Xin, B., Chi, M., Wang, Y., & Guo, C. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200450 · Cited by 32 · see citing works

Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors

Jang, J. Y., Kim, D., & Kim, N. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098457 · Cited by 32 · see citing works

Green modified-UiO-66/MXene sandwich composites for gene-chemotherapy synergistic cancer suppression: Co-delivery of doxorubicin and pCRISPR

Tavakolizadeh, M., Atarod, M., Tabaei, S. J. S., Sojdeh, S., Zare‬, E. N., Rabiee, M., & Rabiee, N. (2023) · Alexandria Engineering Journal · doi:10.1016/j.aej.2023.08.046 · Cited by 32 · see citing works

Doxorubicin-induced phosphorylation of lamin A/C enhances DNMT1 and activates cardiomyocyte death via suppressing GATA-4 and Bcl-xL in rat heart

Tiwari, V., Salgar, S., Jorvekar, S. B., Kumbhar, B. M., Arava, S. K., Borkar, R. M., & Banerjee, S. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167692 · Cited by 5 · see citing works

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity

Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 77 · see citing works

Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature

Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 30 · see citing works

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity

Arrigoni, R., Jirillo, E., & Caiati, C. (2025) · Toxics · doi:10.3390/toxics13040277 · Cited by 37 · see citing works

Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.

Saleh, M. F., El‐Sayad, M. E., & Goda, A. E. (2021) · PubMed · doi:10.26355/eurrev_202111_27100 · Cited by 6 · see citing works